Skip to Content

STO 50 (Carbidopa, entacapone and levodopa 12.5 mg / 200 mg / 50 mg)

Pill imprint STO 50 has been identified as Carbidopa, entacapone and levodopa 12.5 mg / 200 mg / 50 mg.

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 12.5 mg / 200 mg / 50 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbidopa, entacapone and levodopa
Imprint:
STO 50
Strength:
12.5 mg / 200 mg / 50 mg
Color:
Red
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide